Fig. 2From: Anti-phospholipid IgG antibodies detected by line immunoassay differentiate patients with anti-phospholipid syndrome and other autoimmune diseasesConsensus criteria anti-phospholipid antibodies detected by enzyme-linked immunosorbent assays (ELISAs) in 95 subjects including 34 patients with anti-phospholipid syndrome (APS), 41 with systemic autoimmune rheumatic disease (SARD) and no adverse APS events, as well as 20 healthy subjects (children) (HS) as control group. aβ2GPI anti-beta2-glycoprotein I, aCL anti-cardiolipinBack to article page